| 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 核素药物(元) | 499,471,173.31 | 1,017,334,254.84 | 502,378,547.61 |
| 原料药相关产品(元) | 657,180,371.15 | 1,677,555,795.64 | 952,893,490.85 |
| 制剂产品(元) | 179,065,066.84 | 400,155,803.05 | 263,379,078.63 |
| 其他产品(元) | 84,994,763.87 | 180,602,033.10 | 66,359,345.24 |
| 营业成本(元) | |||
| 核素药物(元) | 135,111,890.45 | 277,521,946.57 | 145,873,812.59 |
| 原料药相关产品(元) | 482,407,339.55 | 1,239,748,447.09 | 711,270,677.87 |
| 制剂产品(元) | 110,307,302.49 | 177,607,998.66 | 83,384,725.00 |
| 其他产品(元) | 58,642,734.46 | 111,079,607.06 | 48,422,514.96 |
| 毛利(元) | |||
| 核素药物(元) | 364,359,282.86 | 739,812,308.27 | 356,504,735.02 |
| 原料药相关产品(元) | 174,773,031.60 | 437,807,348.55 | 241,622,812.98 |
| 制剂产品(元) | 68,757,764.35 | 222,547,804.39 | 179,994,353.63 |
| 其他产品(元) | 26,352,029.41 | 69,522,426.04 | 17,936,830.28 |
| 毛利率(%) | |||
| 核素药物(%) | 72.95 | 72.72 | 70.96 |
| 原料药相关产品(%) | 26.59 | 26.10 | 25.36 |
| 制剂产品(%) | 38.40 | 55.62 | 68.34 |
| 其他产品(%) | 31.00 | 38.49 | 27.03 |
| 收入构成(%) | |||
| 核素药物(%) | 35.16 | 31.06 | 28.14 |
| 原料药相关产品(%) | 46.26 | 51.21 | 53.38 |
| 制剂产品(%) | 12.60 | 12.22 | 14.76 |
| 其他产品(%) | 5.98 | 5.51 | 3.72 |
| 毛利构成(%) | |||
| 核素药物(%) | 57.45 | 50.34 | 44.78 |
| 原料药相关产品(%) | 27.56 | 29.79 | 30.35 |
| 制剂产品(%) | 10.84 | 15.14 | 22.61 |
| 其他产品(%) | 4.15 | 4.73 | 2.25 |